Physician profile
Corey S Bruce
NPI 1164423067
$1,172.68
in general payments reported to CMS, 2019-2025
15 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.05 · 2022: $165 · 2023: $249 · 2024: $398 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $367.78 | 2020-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Biogen, INC. | $155.17 | 2024-2025 | Zurzuvae |
| Organon LLC | $148.54 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $146.40 | 2020-2025 | |
| Coopersurgical, INC. | $65.11 | 2024 | Paragard T 380a |
| Astellas Pharma US INC | $64.92 | 2025 | Veozah |
| Pfizer INC. | $55.42 | 2024-2025 | |
| Avanos Medical | $34.56 | 2025 | On-Q Pump and Accessories |
| Teleflex LLC | $24.83 | 2025 | Quikclot |
| Mayne Pharma Commercial LLC | $20.86 | 2023 | |
| Aspira Women'S Health INC | $19.64 | 2023 | Ova1 |
| Smith+Nephew, INC. | $17.94 | 2024 | Pico 14, Pico 7 |
| Shield Therapeutics INC | $17.58 | 2022 | |
| Medline Industries LP | $17.26 | 2022 | |
| Sumitomo Pharma America, INC. | $16.67 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.